会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 21. 发明授权
    • Systems and methods for detecting alternans in intrinsic rhythms to monitor myocardial stability
    • 用于检测内在节律交替的监测心肌稳定性的系统和方法
    • US07697978B1
    • 2010-04-13
    • US11561259
    • 2006-11-17
    • Taraneh Ghaffari Farazi
    • Taraneh Ghaffari Farazi
    • A61B5/04
    • A61B5/0452A61B5/0215A61B5/026A61B5/0535A61B5/1107A61B5/1459A61B5/6852A61B5/686A61B2562/0219A61N1/3627A61N1/3702
    • Implantable systems, and methods for use therewith, are provided for monitoring myocardial stability based on a signal that is indicative of functioning of a patient's heart for a plurality of consecutive beats. Sample data is obtained that is representative of functioning of a patient's heart for a plurality of consecutive beats, wherein each beat has a corresponding cycle length that may differ from cycle lengths of other beats. Such sample data is adjusted so that cycle lengths of consecutive beats represented in the adjusted sample data are substantially equal. Myocardial stability is then monitored based on the adjusted sample data. Where the obtained sample data is representative of electrical functioning of the patient's heart, electrical stability can be monitored, e.g., by monitoring for electrical alternations. Where the obtained sample data is representative of mechanical functioning of the patient's heart, mechanical stability can be monitored, e.g., by monitoring for mechanical alternans.
    • 提供了可植入系统及其使用方法,用于基于指示患者心脏对于多个连续搏动的功能的信号来监测心肌稳定性。 获得代表多个连续节拍的患者心脏的功能的样本数据,其中每个节拍具有可能与其他节拍的周期长度不同的相应周期长度。 调整这样的样本数据,使得在经调整的样本数据中表示的连续节拍的周期长度基本相等。 然后基于经调整的样本数据监测心肌稳定性。 在获得的样本数据代表患者心脏的电功能的情况下,可以例如通过监测电气变化来监测电稳定性。 在获得的样品数据代表患者心脏的机械功能的情况下,可以例如通过监测机械交替物来监测机械稳定性。
    • 25. 发明授权
    • System and method for monitoring diastolic function using an implantable medical device
    • 使用可植入医疗装置监测舒张功能的系统和方法
    • US08874213B2
    • 2014-10-28
    • US13601569
    • 2012-08-31
    • Allen KeelSteve KohTaraneh Ghaffari Farazi
    • Allen KeelSteve KohTaraneh Ghaffari Farazi
    • A61N1/362A61N1/37A61N1/368A61N1/365
    • A61N1/3702A61N1/3627A61N1/36507A61N1/368A61N1/3712
    • Diastolic function is monitored within a patient using a pacemaker or other implantable medical device. In one example, the implantable device uses morphological parameters derived from the T-wave evoked response waveform as proxies for ventricular relaxation rate and ventricular compliance. In particular, the magnitude of the peak of the T-wave evoked response is employed as a proxy for ventricular compliance. The maximum slew rate of the T-wave evoked response following its peak is employed as a proxy for ventricular relaxation. A metric is derived from these proxy values to represent diastolic function. The metric is tracked over time to evaluate changes in diastolic function. In other examples, specific values for ventricular compliance and ventricular relaxation are derived for the patient based on the T-wave evoked response parameters.
    • 使用起搏器或其他可植入医疗器械在患者体内监测舒张功能。 在一个示例中,可植入装置使用从T波诱发反应波形导出的形态参数作为心室松弛率和心室顺应性的代理。 特别地,T波诱发反应的峰值的大小被用作心室顺应性的代表。 其峰值后的T波诱发反应的最大压摆率被用作心室松弛的代用品。 来自这些代理值的度量来表示舒张功能。 随着时间的推移跟踪度量以评估舒张功能的变化。 在其他实例中,基于T波诱发反应参数为患者导出心室顺应性和心室松弛的具体值。
    • 26. 发明授权
    • Subcardiac threshold vagal nerve stimulation
    • 子心脏门槛迷走神经刺激
    • US08473068B2
    • 2013-06-25
    • US12873868
    • 2010-09-01
    • Taraneh Ghaffari Farazi
    • Taraneh Ghaffari Farazi
    • A61N1/36A61N1/368
    • A61N1/368A61N1/3627A61N1/3684A61N1/3688
    • In one embodiment, an implantable stimulation apparatus includes a vagal nerve stimulator configured to generate electrical pulses below a cardiac threshold of a heart, and an electrode coupled to the vagal nerve stimulator which is configured to transmit the electrical pulses below the cardiac threshold, to a vagal nerve so as to inhibit injury resulting from an ischemia and/or reduce injury resulting from an ischemia. In another embodiment, an implantable stimulation apparatus includes a vagal nerve stimulator configured to generate electrical pulses below a cardiac threshold, and includes an electrode, which is coupled to the vagal nerve stimulator and configured transmit electrical pulses to a vagal nerve so as to reduce a defibrillation threshold of the heart.
    • 在一个实施例中,植入式刺激装置包括迷走神经刺激器,其被配置为产生低于心脏心脏阈值的电脉冲,以及耦合到迷走神经刺激器的电极,其被配置为将低于心脏阈值的电脉冲传输到迷走神经刺激器 迷走神经,以抑制由缺血引起的损伤和/或减少由局部缺血引起的损伤。 在另一个实施例中,可植入刺激装置包括迷走神经刺激器,其被配置为产生低于心脏阈值的电脉冲,并且包括耦合到迷走神经刺激器的电极,并配置为迷走神经的传输电脉冲,以减少 心脏除颤阈值。
    • 28. 发明授权
    • Methods and systems for monitoring heart instabilities
    • 监测心脏不稳定的方法和系统
    • US08401627B1
    • 2013-03-19
    • US11848631
    • 2007-08-31
    • Taraneh Ghaffari FaraziFujian Qu
    • Taraneh Ghaffari FaraziFujian Qu
    • A61N1/362
    • A61N1/3702A61N1/36592
    • Systems and method for assessing a patient's myocardial electrical stability by pacing a patient's heart using a pacing sequence that includes at least two different types of pacing pulses. The pacing rate used is preferably only slightly above the patient's intrinsic heart rate. A degree of alternans, in a signal (e.g., IEGM or ECG) that is indicative of cardiac activity in response to the pacing sequence, is determined. The degree of alternans can be determined by comparing portions of the signal that are indicative of cardiac activity in response to the first type of pacing pulses to portions of the signal that are indicative of cardiac activity in response to the second type of pacing pulses. The patient's myocardial electrical stability is assessed based on the determined degree of alternans.
    • 通过使用包括至少两种不同类型的起搏脉冲的起搏序列来对患者的心脏进行起搏来评估患者的心肌电稳定性的系统和方法。 起搏率优选仅略高于患者的内在心率。 确定在响应于起搏序列指示心脏活动的信号(例如,IEGM或ECG)中的交替量的程度。 可以通过将响应于第一类型的起搏脉冲的指示心脏活动的部分的信号的部分与响应于第二类型的起搏脉冲的指示心脏活动的信号的部分进行比较来确定交替的程度。 基于确定的交替量程度评估患者的心肌电稳定性。